Comparative Pharmacovigilance Analysis of Approved and Repurposed Antivirals for COVID-19: Insights from EudraVigilance Data

<b>Background/Objectives</b>: During the COVID-19 pandemic, several antivirals were approved or repurposed, but their safety profiles have not been fully compared. Pharmacovigilance data help clarify how these drugs perform in real-world use. <b>Methods</b>: This study performed a comparative pharma...

Полное описание

Библиографические подробности

Главные авторы:	Paul Andrei Negru, Delia Mirela Tit, Andrei Flavius Radu, Gabriela Bungau, Raluca Anca Corb Aron, Ruxandra Cristina Marin
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2025-06-01
Серии:	Biomedicines
Предметы:	COVID-19 antivirals EudraVigilance pharmacovigilance system organ class individual case safety reports
Online-ссылка:	https://www.mdpi.com/2227-9059/13/6/1387
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!